Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice

Gastroenterology

Volumn 144, Issue 2, 2013, Pages 392-401

  Wei, Haiming ^a,b   Li, Fenglei ^a,b   Wei, Hairong ^b   Gao, Yufeng ^c   Xu, Long ^b   Yin, Wenwei ^b   Sun, Rui ^b   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Hydrodynamic injection; IL 10; Liver disease

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; NATURAL KILLER CELL RECEPTOR NKG2A; ADEFOVIR; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; HEPATITIS B ANTIBODY; HLA ANTIGEN CLASS 1; IMMUNOSUPPRESSIVE AGENT; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; PHOSPHONIC ACID DERIVATIVE; Q SURFACE ANTIGENS; VIRUS DNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL THERAPY; ARTICLE; CELL FUNCTION; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS B; HUMAN; IMMUNE RESPONSE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; UPREGULATION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS TITRATION; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; FLOW CYTOMETRY; GENETICS; HEPATITIS B VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADENINE; ADULT; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; ORGANOPHOSPHONATES; VIRAL LOAD;

EID: 84879315928     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.10.039     Document Type: Article

References (39)

1. Liu J, Fan D. Hepatitis B in China. Lancet 2007;369:1582-1583.
2. Das A, Hoare M, Davies N, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008;205:2111-2124.
3. Nattermann J, Feldmann G, Ahlenstiel G, et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006;55:869-877.
4. Tjwa ET, van Oord GW, Hegmans JP, et al. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011;54:209-218.
5. Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009;51:458-467.
6. Oliviero B, Varchetta S, Paudice E, et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009;137:1151-1160, 1160 e1-e7.
7. Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011;53:73-85.
8. Dunn C, Brunetto M, Reynolds G, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007;204:667-680.
9. Dunn C, Peppa D, Khanna P, et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009;137:1289-1300.
10. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335-352.
11. Moretta L, Bottino C, Pende D, et al. Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 2005;100:7-13.
12. Sun C, Fu B, Gao Y, et al. TGF-beta1 down-regulation of NKG2D/ DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 2012;8:e1002594.
13. Jinushi M, Takehara T, Tatsumi T, et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004;173:6072-6081.
14. Leavenworth JW, Schellack C, Kim HJ, et al. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A 2010;107: 2562-2567.
15. Leavenworth JW, Wang X, Wenander CS, et al. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci U S A 2011;108:14584-14589.
16. Wang J, Sun R, Wei H, et al. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol 2006;44: 446-454.
17. Aktas E, Kucuksezer UC, Bilgic S, et al. Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009; 254:149-154.
18. Huang LR, Wu HL, Chen PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 2006;103:17862-17867.
19. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004;23:255-259.
20. Paust S, Gill HS, Wang BZ, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127-1135.
21. Bertone S, Schiavetti F, Bellomo R, et al. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol 1999;29:23-29.
22. Mingari MC, Ponte M, Bertone S, et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci U S A 1998;95:1172-1177.
23. Lassen MG, Lukens JR, Dolina JS, et al. Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol 2010;184:2693-2701.
24. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001;409:1055-1060.
25. Biron CA, Nguyen KB, Pien GC, et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
26. Jacoby RO, Bhatt PN, Brownstein DG. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol 1989;108:49-58.
27. Tan AT, Koh S, Goh W, et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010;52:330-339.
28. Li J, Wu W, Peng G, et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol 2010;88:834-841.
29. Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010;6:e1001227.
30. Peng G, Li S, Wu W, et al. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008;123:57-65.
31. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-747.
32. El-Badawy O, Sayed D, Badary MS, et al. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection. Hum Immunol 2012;73:335-341.
33. Biron CA. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 1998;10:383-390.
34. Ahlenstiel G, Edlich B, Hogdal LJ, et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 2011;141:1231-1239, 1239 e1-2.
35. Zhang C, Zhang J, Sun R, et al. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells. Int Immunopharmacol 2005;5:1057-1067.
36. Jiang Y, Li W, Yu L, et al. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol 2011;8:75-82.
37. Romagné F, Vivier E. Natural killer cell-based therapies. F1000 Med Rep 2011;3:9.
38. Luevano M, Madrigal A, Saudemont A. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy. Cell Mol Immunol 2012;9:310-320.
39. Konjevic G, Radenkovic S, Srdic T, et al. Association of decreased NK cell activity and IFNgamma expression with pSTAT dysregulation in breast cancer patients. J BUON 2011;16:219-226.